A CLINICAL STUDY TO EVALUATE THE EFFICACY OF DARUHARIDRA GHANAWATI INTERNALLY IN THE MANAGEMENT OF HYPERLIPIDAEMIA WITH SPECIAL REFERENCE TO MEDOROGA

A RANDOMIZED CONTROLLED CLINICAL TRIAL ON EFFICACY OF DARUHARIDRA GHANAWATI INTERNALLY IN THE MANAGEMENT OF HYPERLIPIDAEMIA WITH SPECIAL REFERENCE TO MEDOROGA - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/01/101845

Enrollment

Registered

2026-01-22

Start date

Unknown

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E678- Other specified hyperalimentation

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1 - Patients as per diagnostic criteria 2 - Patients between age group 18-45 years 3 - Patients of either gender 4 - Irrespective of sociological condition of patients

Exclusion criteria

Exclusion criteria: Patients already taking medicines for Hyperlipidemia. patients having lipid levels which are out of range. Patients having any other systemic disorders with complications. Pregnant and lactating women.

Design outcomes

Primary

Measure	Time frame
To study the efficacy of Daruharidra ghanawati 3gm total dose devided in 3 tab BD orally with lukewarm water in the Management of increased lipid profile levelsTimepoint: 30 days of assessment	—

Secondary

Measure	Time frame
To compare the effect of Daruharidra ghanawati & mustadi ghanawati in the Management of Hyperlipidemia Timepoint: 30 days of assessment;To study effect of Daruharidra ghanawati on BMITimepoint: 30 days of assessment;To study the preparation of GhanavatiTimepoint: 30 days of assessment	—

Countries

India

Contacts

Public ContactDr PV Kulkarni

Government Ayurved College, Nanded

kulk.prasad1@gmail.com9405365096

Outcome results